| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $273.7M | +51.8% |
| Cost of Revenue | $76.0M | +17.8% |
| Gross Profit | $197.7M | +70.8% |
| R&D Expense | $34.4M | -7.7% |
| SG&A Expense | $40.2M | +22.7% |
| Operating Income | -$64.9M | +9.6% |
| Pre-tax Income | -$62.3M | +21.4% |
| Income Tax | -$2.6M | -434.8% |
| Net Income | -$59.7M | +25.4% |
| EPS (Basic) | -$1.28 | +31.2% |
| EPS (Diluted) | -$1.28 | +31.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.8M | +8.1% |
| Short-term Investments | $118.4M | — |
| Accounts Receivable | $44.8M | +54.3% |
| Inventory | $55.8M | -14.1% |
| Current Assets | $465.1M | +44.7% |
| Total Assets | $659.4M | +20.3% |
| Current Liabilities | $65.2M | +142.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.2M | +106.7% |
| Capital Expenditures | $2.2M | -1.7% |
| Investing Cash Flow | -$120.4M | +15.8% |
| Financing Cash Flow | $134.0M | -21.4% |
| Free Cash Flow | $968K | +102.0% |
| Total Liabilities |
| $89.2M |
| +36.2% |
| Stockholders' Equity | $570.1M | +18.2% |